Mandating pharmaceutical companies to disclose drug prices as part of Direct-to-Consumer Pharmaceutical Advertising (DTCPA) may reduce consumer interest in high-priced drugs. But the inclusion of modifiers indicating consumers will have zero out-of-pocket costs weakened the finding, according to the results of a behavioral experiment published in JAMA Internal Medicine. 

Tencent, a Chinese multinational investment holding conglomerate, and Merck KGaA, a German-based pharmaceutical, life sciences and technology company, are collaborating to increase disease awareness and provide more accessible healthcare services via digital platforms in China by leveraging AI and big data.

Five major pharmaceutical companies could each lose $500 million or more in revenue per year if a proposal from the Trump administration to reimburse Medicare Part B drugs based on an international pricing index (IPI) is finalized.

Hospitals are now conducting wealth screenings with software that culls public data to see which patients are most likely to donate to the healthcare organization, The New York Times reported. The practice is increasingly common across hospitals, particularly large systems.

Deal volumes broke records in 2018 across the health services sector, and deal activity is likely to remain high in 2019 thanks to a number of positive market factors, according to PwC’s latest health services deals insights.

Media spotlighting of extraordinarily high hospital bills can pay off for patients on the hook for thousands of dollars after a hospital visit. Such is the case for one San Francisco resident who was stuck with a bill for more than $20,000—after her insurance paid its part—following a bicycle accident.

In 2018, the healthcare industry became the largest employment sector in the United States, but rising demand has made certain positions in the space some of the hardest to fill.

The U.S. adult uninsured rate for healthcare reached 13.7 percent at the end of 2018––a four-year high, according to a recent Gallup poll. The findings underscore the actions of the Trump administration to undermine the Affordable Care Act over the last two years.